BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20609697)

  • 21. [Advantages of vasodilating beta-blockers in congestive heart failure].
    Logeart D; Solal AC
    Ann Cardiol Angeiol (Paris); 2010 Jun; 59(3):160-7. PubMed ID: 20620251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of vasodilating beta-blockers in patients with complicated hypertension: focus on nebivolol.
    Giles TD
    Am J Med; 2010 Jul; 123(7 Suppl 1):S16-20. PubMed ID: 20609694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do beta-blockers prolong survival in chronic heart failure? A review of the experimental and clinical evidence.
    Packer M
    Eur Heart J; 1998 Feb; 19 Suppl B():B40-6. PubMed ID: 9519351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide mechanisms of nebivolol.
    Maffei A; Lembo G
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
    Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nebivolol: the somewhat-different beta-adrenergic receptor blocker.
    Münzel T; Gori T
    J Am Coll Cardiol; 2009 Oct; 54(16):1491-9. PubMed ID: 19815121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too].
    MMW Fortschr Med; 2003 May; 145(22):55. PubMed ID: 12866284
    [No Abstract]   [Full Text] [Related]  

  • 28. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD; Bakris GL
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nebivolol: a third-generation beta-adrenergic blocker.
    Veverka A; Nuzum DS; Jolly JL
    Ann Pharmacother; 2006; 40(7-8):1353-60. PubMed ID: 16822893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-blockers in hypertension.
    Ram CV
    Am J Cardiol; 2010 Dec; 106(12):1819-25. PubMed ID: 21126627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The foundation role of beta blockers across the cardiovascular disease spectrum: a year 2009 update.
    Black HR; Greenberg BH; Weber MA
    Am J Med; 2010 Nov; 123(11):S2. PubMed ID: 21035578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
    J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.
    Cockcroft J
    Vasc Health Risk Manag; 2007; 3(6):909-17. PubMed ID: 18200810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.
    Prisant LM
    J Clin Pharmacol; 2008 Feb; 48(2):225-39. PubMed ID: 18083889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive treatment with beta-blockers in the metabolic syndrome: a review.
    Carella AM; Antonucci G; Conte M; Di Pumpo M; Giancola A; Antonucci E
    Curr Diabetes Rev; 2010 Jul; 6(4):215-21. PubMed ID: 20459394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
    MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603611
    [No Abstract]   [Full Text] [Related]  

  • 38. Are tolerability concerns a class effect of beta-blockers in treating patients with hypertension?
    Kountz DS
    Postgrad Med; 2009 Jan; 121(1):14-24. PubMed ID: 19179810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebivolol: a new beta blocker on the horizon.
    Katira R; Chauhan A
    Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.